Search

Your search keyword '"Schriber, Jeffrey"' showing total 215 results
Start Over Author "Schriber, Jeffrey"
215 results on '"Schriber, Jeffrey"'

1. Forte: A Suite of Advanced Multireference Quantum Chemistry Methods

Author

Evangelista, Francesco A., Li, Chenyang, Verma, Prakash, Hannon, Kevin P., Schriber, Jeffrey B., Zhang, Tianyuan, Cai, Chenxi, Wang, Shuhe, He, Nan, Stair, Nicholas H., Huang, Meng, Huang, Renke, Misiewicz, Jonathon P., Li, Shuhang, Marin, Kevin, Zhao, Zijun, and Burns, Lori A.

Subjects
Physics - Chemical Physics
Abstract

Forte is an open-source library specialized in multireference electronic structure theories for molecular systems and the rapid prototyping of new methods. This paper gives an overview of the capabilities of Forte, its software architecture, and examples of applications enabled by the methods it implements.

Published
2024

2. Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.

Author

Saliba, Rima, Alousi, Amin, Pidala, Joseph, Arora, Mukta, Spellman, Stephen, Hemmer, Michael, Wang, Tao, Abboud, Camille, Ahmed, Sairah, Antin, Joseph, Beitinjaneh, Amer, Buchbinder, David, Byrne, Michael, Cahn, Jean-Yves, Choe, Hannah, Hanna, Rabi, Hematti, Peiman, Kamble, Rammurti, Kitko, Carrie, Laughlin, Mary, Lekakis, Lazaros, MacMillan, Margaret, Martino, Rodrigo, Mehta, Parinda, Nishihori, Taiga, Patel, Sagar, Perales, Miguel-Angel, Rangarajan, Hemalatha, Ringdén, Olov, Rosenthal, Joseph, Savani, Bipin, Schultz, Kirk, Seo, Sachiko, Teshima, Takanori, van der Poel, Marjolein, Verdonck, Leo, Weisdorf, Daniel, Wirk, Baldeep, Yared, Jean, Schriber, Jeffrey, Champlin, Richard, and Ciurea, Stefan

Subjects
Graft-versus-host disease, Non-relapse mortality, Post-transplantation cyclophosphamide, Prophylaxis, Antilymphocyte Serum, Cyclophosphamide, Female, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Humans, Male, Retrospective Studies
Abstract

Post-transplantation cyclophosphamide (PTCy) has been shown to effectively control graft-versus-host disease (GvHD) in haploidentical (Haplo) transplantations. In this retrospective registry study, we compared GvHD organ distribution, severity, and outcomes in patients with GvHD occurring after Haplo transplantation with PTCy GvHD prophylaxis (Haplo/PTCy) versus HLA-matched unrelated donor transplantation with conventional prophylaxis (MUD/conventional). We evaluated 2 cohorts: patients with grade 2 to 4 acute GvHD (aGvHD) including 264 and 1163 recipients of Haplo and MUD transplants; and patients with any chronic GvHD (cGvHD) including 206 and 1018 recipients of Haplo and MUD transplants, respectively. In comparison with MUD/conventional transplantation ± antithymocyte globulin (ATG), grade 3-4 aGvHD (28% versus 39%, P = .001), stage 3-4 lower gastrointestinal (GI) tract aGvHD (14% versus 21%, P = .01), and chronic GI GvHD (21% versus 31%, P = .006) were less common after Haplo/PTCy transplantation. In patients with grade 2-4 aGvHD, cGvHD rate after Haplo/PTCY was also lower (hazard ratio [HR] = .4, P < .001) in comparison with MUD/conventional transplantation without ATG in the nonmyeloablative conditioning setting. Irrespective of the use of ATG, non-relapse mortality rate was lower (HR = .6, P = .01) after Haplo/PTCy transplantation, except for transplants that were from a female donor into a male recipient. In patients with cGvHD, irrespective of ATG use, Haplo/PTCy transplantation had lower non-relapse mortality rates (HR = .6, P = .04). Mortality rate was higher (HR = 1.6, P = .03) during, but not after (HR = .9, P = .6) the first 6 months after cGvHD diagnosis. Our results suggest that PTCy-based GvHD prophylaxis mitigates the development of GI GvHD and may translate into lower GvHD-related non-relapse mortality rate.

Published
2022

3. Quantum Chemistry Common Driver and Databases (QCDB) and Quantum Chemistry Engine (QCEngine): Automation and interoperability among computational chemistry programs

Author

Smith, Daniel GA, Lolinco, Annabelle T, Glick, Zachary L, Lee, Jiyoung, Alenaizan, Asem, Barnes, Taylor A, Borca, Carlos H, Di Remigio, Roberto, Dotson, David L, Ehlert, Sebastian, Heide, Alexander G, Herbst, Michael F, Hermann, Jan, Hicks, Colton B, Horton, Joshua T, Hurtado, Adrian G, Kraus, Peter, Kruse, Holger, Lee, Sebastian JR, Misiewicz, Jonathon P, Naden, Levi N, Ramezanghorbani, Farhad, Scheurer, Maximilian, Schriber, Jeffrey B, Simmonett, Andrew C, Steinmetzer, Johannes, Wagner, Jeffrey R, Ward, Logan, Welborn, Matthew, Altarawy, Doaa, Anwar, Jamshed, Chodera, John D, Dreuw, Andreas, Kulik, Heather J, Liu, Fang, Martínez, Todd J, Matthews, Devin A, Schaefer, Henry F, Šponer, Jiří, Turney, Justin M, Wang, Lee-Ping, De Silva, Nuwan, King, Rollin A, Stanton, John F, Gordon, Mark S, Windus, Theresa L, Sherrill, C David, and Burns, Lori A

Subjects
Networking and Information Technology R&D (NITRD), Physical Sciences, Chemical Sciences, Engineering, Chemical Physics
Abstract

Community efforts in the computational molecular sciences (CMS) are evolving toward modular, open, and interoperable interfaces that work with existing community codes to provide more functionality and composability than could be achieved with a single program. The Quantum Chemistry Common Driver and Databases (QCDB) project provides such capability through an application programming interface (API) that facilitates interoperability across multiple quantum chemistry software packages. In tandem with the Molecular Sciences Software Institute and their Quantum Chemistry Archive ecosystem, the unique functionalities of several CMS programs are integrated, including CFOUR, GAMESS, NWChem, OpenMM, Psi4, Qcore, TeraChem, and Turbomole, to provide common computational functions, i.e., energy, gradient, and Hessian computations as well as molecular properties such as atomic charges and vibrational frequency analysis. Both standard users and power users benefit from adopting these APIs as they lower the language barrier of input styles and enable a standard layout of variables and data. These designs allow end-to-end interoperable programming of complex computations and provide best practices options by default.

Published
2021

4. Time Dependent Adaptive Configuration Interaction Applied to Attosecond Charge Migration

Author

Schriber, Jeffrey B. and Evangelista, Francesco A.

Subjects
Physics - Chemical Physics
Abstract

In this work, we present a time-dependent (TD) selected configuration interaction method based on our recently-introduced adaptive configuration interaction (ACI). We show that ACI, in either its ground or excited state formalisms, is capable of building a compact basis for use in real-time propagation of wave functions for computing electron dynamics. TD-ACI uses an iteratively selected basis of determinants in real-time propagation capable of capturing strong correlation effects in both ground and excited states, all with an accuracy---and associated cost---tunable by the user. We apply TD-ACI to study attosecond-scale migration of charge following ionization in small molecules. We first compute attosecond charge dynamics in a benzene model to benchmark and understand the utility of TD-ACI with respect to an exact solution. Finally, we use TD-ACI to reproduce experimentally determined ultrafast charge migration dynamics in iodoacetylene. TD-ACI is shown to be a valuable benchmark theory for electron dynamics, and it represents an important step towards accurate and affordable time-dependent multireference methods., Comment: 7 pages, 3 figures

Published
2019
Full Text
View/download PDF

6. A Combined Selected Configuration Interaction and Many-Body Treatment of Static and Dynamical Correlation in Oligoacenes

Author

Schriber, Jeffrey B., Hannon, Kevin P., and Evangelista, Francesco A.

Subjects
Physics - Chemical Physics
Abstract

We have combined our adaptive configuration interaction (ACI) [J.B. Schriber and F.A. Evangelista, J. Chem. Phys. 144, 161106 (2016)] with a density-fitted implementation of the second-order perturbative multireference driven similarity renormalization group (DSRG-MRPT2) [K.P. Hannon, C. Li and F.A. Evangelista J. Chem. Phys. 144, 204111 (2016)]. We use ACI reference wave functions to recover static correlation for active spaces larger than the conventional limit of 18 orbitals. The dynamical correlation is computed using the DSRG-MRPT2 to yield a complete treatment of electron correlation. We apply the resulting method, ACI-DSRG-MRPT2, to predict singlet-triplet gaps, metrics of open-shell character, and spin-spin correlation functions for the oligoacene series (2-7 rings). Our computations employ active spaces with as many as 30 electrons in 30 orbitals and up to 1350 basis functions, yielding gaps that are in good agreement with available experimental results. Large bases and reference relaxation lead to a significant reduction in the estimated radical character of the oligoacenes with respect to previous valence-only treatments of correlation effects.

Published
2018

7. Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.

Author

Pulsipher, Michael A, Logan, Brent R, Kiefer, Deidre M, Chitphakdithai, Pintip, Riches, Marcie L, Rizzo, J Douglas, Anderlini, Paolo, Leitman, Susan F, Varni, James W, Kobusingye, Hati, Besser, RaeAnne M, Miller, John P, Drexler, Rebecca J, Abdel-Mageed, Aly, Ahmed, Ibrahim A, Ball, Edward D, Bolwell, Brian J, Bunin, Nancy J, Cheerva, Alexandra, Delgado, David C, Dvorak, Christopher C, Gillio, Alfred P, Hahn, Theresa E, Hale, Gregory A, Haight, Ann E, Hayes-Lattin, Brandon M, Kasow, Kimberly A, Linenberger, Michael, Magalhaes-Silverman, Margarida, Mori, Shahram, Prasad, Vinod K, Quigg, Troy C, Sahdev, Indira, Schriber, Jeffrey R, Shenoy, Shalini, Tse, William T, Yanik, Gregory A, Navarro, Willis H, Horowitz, Mary M, Confer, Dennis L, Shaw, Bronwen E, and Switzer, Galen E

Subjects
Humans, Pain, Tissue and Organ Harvesting, Bone Marrow Transplantation, Transplantation, Homologous, Age Factors, Sex Factors, Time Factors, Adolescent, Tissue Donors, Female, Male, BM collection toxicities, Donor safety, PBSC collection toxicities, Stem cell transplantation, Transplantation, Chronic Pain, Neurosciences, Pediatric, Clinical Research, Stem Cell Research, Pain Research, Clinical Trials and Supportive Activities, Prevention, Immunology, Clinical Sciences
Abstract

Although donation of bone marrow (BM) or peripheral blood stem cells (PBSCs) from children to family members undergoing allogeneic transplantation are well-established procedures, studies detailing levels of pain, symptoms, and long-term recovery are lacking. To address this lack, we prospectively enrolled 294 donors age 20% of females and males age 13 to 17 years do not return to baseline pain levels by 1 year after BM donation. Studies aimed at decreasing symptoms and improving recovery in older children are warranted.

Published
2019

8. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors

Author

Pulsipher, Michael A, Logan, Brent R, Kiefer, Deidre M, Chitphakdithai, Pintip, Riches, Marcie L, Rizzo, J Douglas, Anderlini, Paolo, Leitman, O’Susan F, Kobusingye, Hati, Besser, RaeAnne M, Miller, John P, Drexler, Rebecca J, Abdel-Mageed, Aly, Ahmed, Ibrahim A, Akard, Luke P, Artz, Andrew S, Ball, Edward D, Bayer, Ruthee-Lu, Bigelow, Carolyn, Bolwell, Brian J, Broun, E Randolph, Delgado, David C, Duckworth, Katharine, Dvorak, Christopher C, Hahn, Theresa E, Haight, Ann E, Hari, Parameswaran N, Hayes-Lattin, Brandon M, Jacobsohn, David A, Jakubowski, Ann A, Kasow, Kimberly A, Lazarus, Hillard M, Liesveld, Jane L, Linenberger, Michael, Litzow, Mark R, Longo, Walter, Magalhaes-Silverman, Margarida, McCarty, John M, McGuirk, Joseph P, Mori, Shahram, Parameswaran, Vinod, Prasad, Vinod K, Rowley, Scott D, Rybka, Witold B, Sahdev, Indira, Schriber, Jeffrey R, Selby, George B, Shaughnessy, Paul J, Shenoy, Shalini, Spitzer, Thomas, Tse, William T, Uberti, Joseph P, Vusirikala, Madhuri, Waller, Edmund K, Weisdorf, Daniel J, Yanik, Gregory A, Navarro, Willis H, Horowitz, Mary M, Switzer, Galen E, Confer, Dennis L, and Shaw, Bronwen E

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Transplantation, Patient Safety, Regenerative Medicine, Clinical Research, Neurosciences, Stem Cell Research - Nonembryonic - Human, Chronic Pain, Pain Research, Stem Cell Research, Adolescent, Adult, Female, Humans, Living Donors, Male, Middle Aged, Peripheral Blood Stem Cell Transplantation, Peripheral Blood Stem Cells, Prospective Studies, Quality of Life, Unrelated Donors, Young Adult, Cardiorespiratory Medicine and Haematology, Immunology, Cardiovascular medicine and haematology
Abstract

Unlike unrelated donor registries, transplant centers lack uniform approaches to related donor assessment and deferral. To test whether related donors are at increased risk for donation-related toxicities, we conducted a prospective observational trial of 11,942 related and unrelated donors aged 18-60 years. Bone marrow (BM) was collected at 37 transplant and 78 National Marrow Donor Program centers, and peripheral blood stem cells (PBSC) were collected at 42 transplant and 87 unrelated donor centers in North America. Possible presence of medical comorbidities was verified prior to donation, and standardized pain and toxicity measures were assessed pre-donation, peri-donation, and one year following. Multivariate analyses showed similar experiences for BM collection in related and unrelated donors; however, related stem cell donors had increased risk of moderate [odds ratios (ORs) 1.42; P

Published
2019

9. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Author

Pulsipher, Michael A, Logan, Brent R, Chitphakdithai, Pintip, Kiefer, Deidre M, Riches, Marcie L, Rizzo, J Douglas, Anderlini, Paolo, Leitman, Susan F, Varni, James W, Kobusingye, Hati, Besser, RaeAnne M, Miller, John P, Drexler, Rebecca J, Abdel-Mageed, Aly, Ahmed, Ibrahim A, Akard, Luke P, Artz, Andrew S, Ball, Edward D, Bayer, Ruthee-Lu, Bigelow, Carolyn, Bolwell, Brian J, Broun, E Randolph, Bunin, Nancy J, Delgado, David C, Duckworth, Katharine, Dvorak, Christopher C, Hahn, Theresa E, Haight, Ann E, Hari, Parameswaran N, Hayes-Lattin, Brandon M, Jacobsohn, David A, Jakubowski, Ann A, Kasow, Kimberly A, Lazarus, Hillard M, Liesveld, Jane L, Linenberger, Michael, Litzow, Mark R, Longo, Walter, Magalhaes-Silverman, Margarida, McCarty, John M, McGuirk, Joseph P, Mori, Shahram, Prasad, Vinod K, Rowley, Scott D, Rybka, Witold B, Sahdev, Indira, Schriber, Jeffrey R, Selby, George B, Shaughnessy, Paul J, Shenoy, Shalini, Spitzer, Thomas, Tse, William T, Uberti, Joseph P, Vusirikala, Madhuri, Waller, Edmund K, Weisdorf, Daniel J, Yanik, Gregory A, Navarro, Willis H, Horowitz, Mary M, Switzer, Galen E, Shaw, Bronwen E, and Confer, Dennis L

Subjects
Humans, Peripheral Blood Stem Cell Transplantation, Comorbidity, Adolescent, Adult, Aged, Middle Aged, Blood Donors, Female, Male, Young Adult, Peripheral Blood Stem Cells, BM collection toxicities, Donor safety, PBSC collection toxicities, Stem cell transplantation, Transplantation, Pain Research, Stem Cell Research - Nonembryonic - Human, Clinical Research, Chronic Pain, Stem Cell Research, Aging, Clinical Sciences, Immunology
Abstract

The development of reduced-intensity approaches for allogeneic hematopoietic cell transplantation has resulted in growing numbers of older related donors (RDs) of peripheral blood stem cells (PBSCs). The effects of age on donation efficacy, toxicity, and long-term recovery in RDs are poorly understood. To address this we analyzed hematologic variables, pain, donation-related symptoms, and recovery in 1211 PBSC RDs aged 18 to 79 enrolled in the Related Donor Safety Study. RDs aged > 60 had a lower median CD34+ level before apheresis compared with younger RDs (age > 60, 59 × 106/L; age 41 to 60, 81 × 106/L; age 18 to 40, 121 × 106/L; P < .001). This resulted in older donors undergoing more apheresis procedures (49% versus 30% ≥ 2 collections, P < .001) and higher collection volumes (52% versus 32% > 24 L, P < .001), leading to high percentages of donors aged > 60 with postcollection thrombocytopenia

Published
2019

10. An adaptive configuration interaction approach for strongly correlated electrons with tunable accuracy

Author

Schriber, Jeffrey B. and Evangelista, Francesco A.

Subjects
Physics - Chemical Physics, Condensed Matter - Strongly Correlated Electrons
Abstract

We introduce a new procedure for iterative selection of determinant spaces capable of describing highly correlated systems. This adaptive configuration interaction (ACI) determines an optimal basis by an iterative procedure in which the determinant space is expanded and coarse grained until self consistency. Two importance criteria control the selection process and tune the ACI to a user-defined level of accuracy. The ACI is shown to yield potential energy curves of N$_2$ with nearly constant errors, and it predicts singlet-triplet splittings of acenes up to decacene that are in good agreement with the density matrix renormalization group.

Published
2016
Full Text
View/download PDF

11. Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Author

Dhakal, Binod, Patel, Sagar, Girnius, Saulius, Bachegowda, Lohith, Fraser, Raphael, Davila, Omar, Kanate, Abraham S., Assal, Amer, Hanbali, Amr, Bashey, Asad, Pawarode, Attaphol, Freytes, César O., Lee, Cindy, Vesole, David, Cornell, Robert Frank, Hildebrandt, Gerhard C., Murthy, Hemant S., Lazarus, Hillard M., Cerny, Jan, Yared, Jean A., Schriber, Jeffrey, Berdeja, Jesus, Stockerl-Goldstein, Keith, Meehan, Kenneth, Holmberg, Leona, Solh, Melhem, Diaz, Miguel Angel, Kharfan-Dabaja, Mohamed A., Farhadfar, Nosha, Bashir, Qaiser, Munker, Reinhold, Olsson, Richard F., Gale, Robert P., Bayer, Ruthlee-Lu, Seo, Sachiko, Chhabra, Saurabh, Hashmi, Shahrukh, Badawy, Sherif M., Nishihori, Taiga, Gonsalves, Wilson, Nieto, Yago, Efebera, Yvonne, Kumar, Shaji, Shah, Nina, Qazilbash, Muzaffar, Hari, Parameswaran, and D’Souza, Anita

Published
2020
Full Text
View/download PDF

12. A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia

Author

Zeidner, Joshua F., Lin, Tara L., Vigil, Carlos E., Fine, Gil, Yair Levy, M., Nazha, Aziz, Esteve, Jordi, Lee, Daniel J., Yee, Karen, Dalovisio, Andrew, Wang, Eunice S., Bergua Burgues, Juan M., Schriber, Jeffrey, Litzow, Mark R., Frankfurt, Olga, Castillo, Teresa Bernal Del, Bhatt, Vijaya Raj, Bhatnagar, Bhavana, Mehta, Priyanka, Dillon, Richard, Vicente, Maria Vidriales, Anthony, Stephen, Bearss, David, Montesinos, Pau, and Douglas Smith, B.

Published
2021
Full Text
View/download PDF

13. “Democratizing” cancer care: City of Hope’s national enterprise model for delivering cancer care.

Author

Schriber, Jeffrey, primary, Artz, Andrew S., additional, Purvis, Amy, additional, Slack, James L., additional, Larsen, Jeremy Todd, additional, Park, Soyoung, additional, Tulipana, Kevin Frank, additional, Majkowski, Gemini, additional, Nakamura, Ryotaro, additional, Popplewell, Leslie, additional, Herrera, Alex Francisco, additional, Budde, Lihua Elizabeth, additional, Koller, Paul B., additional, Janakiram, Murali, additional, Ball, Brian, additional, Phillips, Tycel Jovelle, additional, Rosenzweig, Michael Alan, additional, Marcucci, Guido, additional, Smith, Eileen P., additional, and Stewart, Forrest, additional

Published
2023
Full Text
View/download PDF

15. Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Author

Dhakal, Binod, Patel, Sagar, Girnius, Saulius, Bachegowda, Lohith, Fraser, Raphael, Davila, Omar, Kanate, Abraham S., Assal, Amer, Hanbali, Amr, Bashey, Asad, Pawarode, Attaphol, Freytes, César O., Lee, Cindy, Vesole, David, Cornell, Robert Frank, Hildebrandt, Gerhard C., Murthy, Hemant S., Lazarus, Hillard M., Cerny, Jan, Yared, Jean A., Schriber, Jeffrey, Berdeja, Jesus, Stockerl-Goldstein, Keith, Meehan, Kenneth, Holmberg, Leona, Solh, Melhem, Diaz, Miguel Angel, Kharfan-Dabaja, Mohamed A., Farhadfar, Nosha, Bashir, Qaiser, Munker, Reinhold, Olsson, Richard F., Gale, Robert P., Bayer, Ruthlee-Lu, Seo, Sachiko, Chhabra, Saurabh, Hashmi, Shahrukh, Badawy, Sherif M., Nishihori, Taiga, Gonsalves, Wilson, Nieto, Yago, Efebera, Yvonne, Kumar, Shaji, Shah, Nina, Qazilbash, Muzaffar, Hari, Parameswaran, and D’Souza, Anita

Published
2021
Full Text
View/download PDF

16. Optimized damping parameters for empirical dispersion corrections to symmetry-adapted perturbation theory.

Author

Schriber, Jeffrey B., Sirianni, Dominic A., Smith, Daniel G. A., Burns, Lori A., Sitkoff, Doree, Cheney, Daniel L., and Sherrill, C. David

Subjects
*PERTURBATION theory, *DISPERSION (Chemistry), *ADRENERGIC receptors, *G protein coupled receptors, *QUANTUM mechanics
Abstract

Symmetry-adapted perturbation theory (SAPT) has become an invaluable tool for studying the fundamental nature of non-covalent interactions by directly computing the electrostatics, exchange (steric) repulsion, induction (polarization), and London dispersion contributions to the interaction energy using quantum mechanics. Further application of SAPT is primarily limited by its computational expense, where even its most affordable variant (SAPT0) scales as the fifth power of system size [ O ( N 5 ) ] due to the dispersion terms. The algorithmic scaling of SAPT0 is reduced from O ( N 5 ) → O ( N 4 ) by replacing these terms with the empirical D3 dispersion correction of Grimme and co-workers, forming a method that may be termed SAPT0-D3. Here, we optimize the damping parameters for the -D3 terms in SAPT0-D3 using a much larger training set than has previously been considered, namely, 8299 interaction energies computed at the complete-basis-set limit of coupled cluster through perturbative triples [CCSD(T)/CBS]. Perhaps surprisingly, with only three fitted parameters, SAPT0-D3 improves on the accuracy of SAPT0, reducing mean absolute errors from 0.61 to 0.49 kcal mol−1 over the full set of complexes. Additionally, SAPT0-D3 exhibits a nearly 2.5× speedup over conventional SAPT0 for systems with ∼300 atoms and is applied here to systems with up to 459 atoms. Finally, we have also implemented a functional group partitioning of the approach (F-SAPT0-D3) and applied it to determine important contacts in the binding of salbutamol to G-protein coupled β1-adrenergic receptor in both active and inactive forms. SAPT0-D3 capabilities have been added to the open-source Psi4 software. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

17. CLIFF: A component-based, machine-learned, intermolecular force field.

Author

Schriber, Jeffrey B., Nascimento, Daniel R., Koutsoukas, Alexios, Spronk, Steven A., Cheney, Daniel L., and Sherrill, C. David

Subjects
*INTERMOLECULAR forces, *CLIFFS, *INTERMOLECULAR interactions, *LIGAND binding (Biochemistry), *PERTURBATION theory, *PROTEIN-ligand interactions
Abstract

Computation of intermolecular interactions is a challenge in drug discovery because accurate ab initio techniques are too computationally expensive to be routinely applied to drug–protein models. Classical force fields are more computationally feasible, and force fields designed to match symmetry adapted perturbation theory (SAPT) interaction energies can remain accurate in this context. Unfortunately, the application of such force fields is complicated by the laborious parameterization required for computations on new molecules. Here, we introduce the component-based machine-learned intermolecular force field (CLIFF), which combines accurate, physics-based equations for intermolecular interaction energies with machine-learning models to enable automatic parameterization. The CLIFF uses functional forms corresponding to electrostatic, exchange-repulsion, induction/polarization, and London dispersion components in SAPT. Molecule-independent parameters are fit with respect to SAPT2+(3)δMP2/aug-cc-pVTZ, and molecule-dependent atomic parameters (atomic widths, atomic multipoles, and Hirshfeld ratios) are obtained from machine learning models developed for C, N, O, H, S, F, Cl, and Br. The CLIFF achieves mean absolute errors (MAEs) no worse than 0.70 kcal mol−1 in both total and component energies across a diverse dimer test set. For the side chain–side chain interaction database derived from protein fragments, the CLIFF produces total interaction energies with an MAE of 0.27 kcal mol−1 with respect to reference data, outperforming similar and even more expensive methods. In applications to a set of model drug–protein interactions, the CLIFF is able to accurately rank-order ligand binding strengths and achieves less than 10% error with respect to SAPT reference values for most complexes. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

18. Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation

Author

Shah, Nina, Callander, Natalie, Ganguly, Siddhartha, Gul, Zartash, Hamadani, Mehdi, Costa, Luciano, Sengsayadeth, Salyka, Abidi, Muneer, Hari, Parameswaran, Mohty, Mohamad, Chen, Yi-Bin, Koreth, John, Landau, Heather, Lazarus, Hillard, Leather, Helen, Majhail, Navneet, Nath, Rajneesh, Osman, Keren, Perales, Miguel-Angel, Schriber, Jeffrey, Shaughnessy, Paul, Vesole, David, Vij, Ravi, Wingard, John, Giralt, Sergio, and Savani, Bipin N.

Published
2015
Full Text
View/download PDF

19. Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma: Guidelines from the American Society for Blood and Marrow Transplantation

Author

Perales, Miguel-Angel, Ceberio, Izaskun, Armand, Philippe, Burns, Linda J., Chen, Robert, Cole, Peter D., Evens, Andrew M., Laport, Ginna G., Moskowitz, Craig H., Popat, Uday, Reddy, Nishitha M., Shea, Thomas C., Vose, Julie M., Schriber, Jeffrey, Savani, Bipin N., and Carpenter, Paul A.

Published
2015
Full Text
View/download PDF

21. Psi4 1.4: Open-source software for high-throughput quantum chemistry.

Author

Smith, Daniel G. A., Burns, Lori A., Simmonett, Andrew C., Parrish, Robert M., Schieber, Matthew C., Galvelis, Raimondas, Kraus, Peter, Kruse, Holger, Di Remigio, Roberto, Alenaizan, Asem, James, Andrew M., Lehtola, Susi, Misiewicz, Jonathon P., Scheurer, Maximilian, Shaw, Robert A., Schriber, Jeffrey B., Xie, Yi, Glick, Zachary L., Sirianni, Dominic A., and O'Brien, Joseph Senan

Subjects
QUANTUM chemistry, PYTHON programming language, PERTURBATION theory, COUPLED-cluster theory, TEXT files, DENSITY functional theory
Abstract

PSI4 is a free and open-source ab initio electronic structure program providing implementations of Hartree–Fock, density functional theory, many-body perturbation theory, configuration interaction, density cumulant theory, symmetry-adapted perturbation theory, and coupled-cluster theory. Most of the methods are quite efficient, thanks to density fitting and multi-core parallelism. The program is a hybrid of C++ and Python, and calculations may be run with very simple text files or using the Python API, facilitating post-processing and complex workflows; method developers also have access to most of PSI4's core functionalities via Python. Job specification may be passed using The Molecular Sciences Software Institute (MolSSI) QCSCHEMA data format, facilitating interoperability. A rewrite of our top-level computation driver, and concomitant adoption of the MolSSI QCARCHIVE INFRASTRUCTURE project, makes the latest version of PSI4 well suited to distributed computation of large numbers of independent tasks. The project has fostered the development of independent software components that may be reused in other quantum chemistry programs. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

22. Salvage Second Hematopoietic Cell Transplantation in Myeloma

Author

Michaelis, Laura C., Saad, Ayman, Zhong, Xiaobo, Le-Rademacher, Jennifer, Freytes, Cesar O., Marks, David I., Lazarus, Hillard M., Bird, Jennifer M., Holmberg, Leona, Kamble, Rammurti T., Kumar, Shaji, Lill, Michael, Meehan, Kenneth R., Saber, Wael, Schriber, Jeffrey, Tay, Jason, Vogl, Dan T., Wirk, Baldeep, Savani, Bipin N., Gale, Robert P., Vesole, David H., Schiller, Gary J., Abidi, Muneer, Anderson, Kenneth C., Nishihori, Taiga, Kalaycio, Matt E., Vose, Julie M., Moreb, Jan S., Drobyski, William, Munker, Reinhold, Roy, Vivek, Ghobadi, Armin, Holland, H. Kent, Nath, Rajneesh, To, L. Bik, Maiolino, Angelo, Kassim, Adetola A., Giralt, Sergio A., Landau, Heather, Schouten, Harry C., Maziarz, Richard T., Michael, Joseph, Kindwall-Keller, Tamila, Stiff, Patrick J., Gibson, John, Lonial, Sagar, Krishnan, Amrita, Dispenzieri, Angela, and Hari, Parameswaran

Published
2013
Full Text
View/download PDF

25. Impact of Graft Cell Dose on Transplant Outcomes following Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplantation: Higher CD34 + Cell Doses Are Associated with Decreased Relapse Rates

Author

Nakamura, Ryotaro, Auayporn, Nademanee, Smith, David D., Palmer, Joycelynne, Sun, Joel Y., Schriber, Jeffrey, Pullarkat, Vinod, Parker, Pablo, Rodriguez, Roberto, Stein, Anthony, Rosenthal, Joseph, Wang, Shirong, Karanas, Chatchada, Gaal, Karl, Senitzer, David, and Forman, Stephen J.

Published
2008
Full Text
View/download PDF

27. Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma

Author

Munshi, Pashna N., primary, Vesole, David, additional, Jurczyszyn, Artur, additional, Zaucha, Jan Maciej, additional, St. Martin, Andrew, additional, Davila, Omar, additional, Agrawal, Vaibhav, additional, Badawy, Sherif M., additional, Battiwalla, Minoo, additional, Chhabra, Saurabh, additional, Copelan, Edward, additional, Kharfan‐Dabaja, Mohamed A., additional, Farhadfar, Nosha, additional, Ganguly, Siddhartha, additional, Hashmi, Shahrukh, additional, Krem, Maxwell M., additional, Lazarus, Hillard M., additional, Malek, Ehsan, additional, Meehan, Kenneth, additional, Murthy, Hemant S., additional, Nishihori, Taiga, additional, Olin, Rebecca L., additional, Olsson, Richard F., additional, Schriber, Jeffrey, additional, Seo, Sachiko, additional, Shah, Gunjan, additional, Solh, Melhem, additional, Tay, Jason, additional, Kumar, Shaji, additional, Qazilbash, Muzaffar H., additional, Shah, Nina, additional, Hari, Parameswaran N., additional, and D’Souza, Anita, additional

Published
2020
Full Text
View/download PDF

28. Psi41.4: Open-source software for high-throughput quantum chemistry

Author

Smith, Daniel G. A., primary, Burns, Lori A., additional, Simmonett, Andrew C., additional, Parrish, Robert M., additional, Schieber, Matthew C., additional, Galvelis, Raimondas, additional, Kraus, Peter, additional, Kruse, Holger, additional, Di Remigio, Roberto, additional, Alenaizan, Asem, additional, James, Andrew M., additional, Lehtola, Susi, additional, Misiewicz, Jonathon P., additional, Scheurer, Maximilian, additional, Shaw, Robert A., additional, Schriber, Jeffrey B., additional, Xie, Yi, additional, Glick, Zachary L., additional, Sirianni, Dominic A., additional, O’Brien, Joseph Senan, additional, Waldrop, Jonathan M., additional, Kumar, Ashutosh, additional, Hohenstein, Edward G., additional, Pritchard, Benjamin P., additional, Brooks, Bernard R., additional, Schaefer, Henry F., additional, Sokolov, Alexander Yu., additional, Patkowski, Konrad, additional, DePrince, A. Eugene, additional, Bozkaya, Uğur, additional, King, Rollin A., additional, Evangelista, Francesco A., additional, Turney, Justin M., additional, Crawford, T. Daniel, additional, and Sherrill, C. David, additional

Published
2020
Full Text
View/download PDF

29. Psi4 1.4: Open-Source Software for High-Throughput Quantum Chemistry

Author

Smith, Daniel, primary, Burns, Lori, additional, Simmonett, Andrew, additional, Parrish, Robert, additional, Schieber, Matthew, additional, Galvelis, Raimondas, additional, Kraus, Peter, additional, Kruse, Holger, additional, Di Remigio, Roberto, additional, Alenaizan, Asem, additional, James, Andrew, additional, Lehtola, Susi, additional, Misiewicz, Jonathon, additional, Scheurer, Maximilian, additional, Shaw, Robert, additional, Schriber, Jeffrey, additional, Xie, Yi, additional, Glick, Zachary, additional, Sirianni, Dominic, additional, O'Brien, Joseph, additional, Waldrop, Jonathan, additional, Kumar, Ashutosh, additional, Hohenstein, Edward G., additional, Pritchard, Benjamin, additional, Brooks, Bernard, additional, Schaefer, Henry, additional, Sokolov, Alexander, additional, Patkowski, Konrad, additional, DePrince, Eugene, additional, Bozkaya, Ugur, additional, King, Rollin, additional, Evangelista, Francesco, additional, Turney, Justin, additional, Crawford, Thomas, additional, and Sherrill, David, additional

Published
2020
Full Text
View/download PDF

30. Acute Graft-Versus-Host Disease Is Less Severe and Associated with Lower Non-Relapse Mortality after Haploidentical Transplantation with Post-Cyclophosphamide Prophylaxis

Author

Saliba, Rima M., primary, Arora, Mukta, additional, Spellman, Stephen R., additional, Hemmer, Michael T., additional, Wang, Tao, additional, Alousi, Amin M., additional, Pidala, Joseph A., additional, Jagasia, Madan, additional, MacMillan, Margaret L., additional, Horowitz, Mary M., additional, Schriber, Jeffrey, additional, Champlin, Richard E., additional, and Ciurea, Stefan O., additional

Published
2020
Full Text
View/download PDF

33. Communication: An adaptive configuration interaction approach for strongly correlated electrons with tunable accuracy.

Author

Schriber, Jeffrey B. and Evangelista, Francesco A.

Subjects
*ELECTRONS, *POTENTIAL energy, *NITROGEN, *RENORMALIZATION group theory (Statistical physics), *DENSITY matrices
Abstract

We introduce a newprocedure for iterative selection of determinant spaces capable of describing highly correlated systems. This adaptive configuration interaction (ACI) determines an optimal basis by an iterative procedure in which the determinant space is expanded and coarse grained until self-consistency. Two importance criteria control the selection process and tune the ACI to a user-defined level of accuracy. The ACI is shown to yield potential energy curves of N2 with nearly constant errors, and it predicts singlet-triplet splittings of acenes up to decacene that are in good agreement with the density matrix renormalization group. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

36. Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML)

Author

Zeidner, Joshua F, primary, Lin, Tara L, additional, Vigil, Carlos E, additional, Dalovisio, Andrew, additional, Wang, Eunice S., additional, Levy, Moshe Yair, additional, Frattini, Mark G., additional, Lee, Daniel J., additional, Montesinos, Pau, additional, Bergua Burgues, Juan Miguel Miguel, additional, Schriber, Jeffrey R., additional, Anthony, Stephen, additional, Bearss, David J., additional, and Smith, B. Douglas, additional

Published
2018
Full Text
View/download PDF

38. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors

Author

Pulsipher, Michael A., primary, Logan, Brent R., additional, Kiefer, Deidre M., additional, Chitphakdithai, Pintip, additional, Riches, Marcie L., additional, Rizzo, J. Douglas, additional, Anderlini, Paolo, additional, Leitman, O’Susan F., additional, Kobusingye, Hati, additional, Besser, RaeAnne M., additional, Miller, John P., additional, Drexler, Rebecca J., additional, Abdel-Mageed, Aly, additional, Ahmed, Ibrahim A., additional, Akard, Luke P., additional, Artz, Andrew S., additional, Ball, Edward D., additional, Bayer, Ruthee-Lu, additional, Bigelow, Carolyn, additional, Bolwell, Brian J., additional, Broun, E. Randolph, additional, Delgado, David C., additional, Duckworth, Katharine, additional, Dvorak, Christopher C., additional, Hahn, Theresa E., additional, Haight, Ann E., additional, Hari, Parameswaran N., additional, Hayes-Lattin, Brandon M., additional, Jacobsohn, David A., additional, Jakubowski, Ann A., additional, Kasow, Kimberly A., additional, Lazarus, Hillard M., additional, Liesveld, Jane L., additional, Linenberger, Michael, additional, Litzow, Mark R., additional, Longo, Walter, additional, Magalhaes-Silverman, Margarida, additional, McCarty, John M., additional, McGuirk, Joseph P., additional, Mori, Shahram, additional, Parameswaran, Vinod, additional, Prasad, Vinod K., additional, Rowley, Scott D., additional, Rybka, Witold B., additional, Sahdev, Indira, additional, Schriber, Jeffrey R., additional, Selby, George B., additional, Shaughnessy, Paul J., additional, Shenoy, Shalini, additional, Spitzer, Thomas, additional, Tse, William T., additional, Uberti, Joseph P., additional, Vusirikala, Madhuri, additional, Waller, Edmund K., additional, Weisdorf, Daniel J., additional, Yanik, Gregory A., additional, Navarro, Willis H., additional, Horowitz, Mary M., additional, Switzer, Galen E., additional, Confer, Dennis L., additional, and Shaw, Bronwen E., additional

Published
2018
Full Text
View/download PDF

40. Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies

Author

Long, Gwynn D., Negrin, Robert S., Hoyle, Christine F., Kusnierz-Glaz, Claus R., Schriber, Jeffrey R., Blume, Karl G., and Chao, Nelson J.

Subjects
Breast cancer -- Care and treatment, Chemotherapy -- Usage, Non-Hodgkin's lymphomas -- Care and treatment, Hematopoietic stem cells -- Health aspects, Health
Abstract

Background. Retrospective studies suggest that dose intensity is an important determinant of outcome in the treatment of patients with a variety of malignant diseases such as breast cancer, ovarian cancer, and lymphoma. Unfortunately, these results have not been clearly substantiated in prospective randomized trials. One problem with these studies may be that the degree of dose escalation is not sufficient to result in an improved outcome because the chemotherapy doses are limited by hematopoietic toxicity. In an attempt to deliver more dose-intensive therapy, the feasibility of the administration of multiple cycles of high dose chemotherapy with hematopoietic progenitor cell and growth factor support was investigated in patients with advanced malignancies. Methods. Nineteen patients with metastatic breast cancer and six patients with refractory non-Hodgkin's lymphoma were initially treated with etoposide (VP-16) (2 gm/[m.sup.2]) and granulocyte-colony stimulating factor (G-CSF). Peripheral blood hematopoietic progenitor cells were collected by leukapheresis and cryopreserved as the patients' leukocyte counts recovered from the nadir induced by VP-16. Patients were then treated with four cycles of mitoxantrone (18 mg/[m.sup.2]), thiotepa (150-200 mg/[m.sup.2]) and cyclophosphamide (4500-5000 mg/[m.sup.2]) as a 48-72 hour continuous infusion followed by infusion of one-quarter of their progenitor cells 48 hours later. All patients also received G-CSF (5 [micro]g/kg/day) until engraftment. Results. A total of 88 of a planned 100 cycles of therapy were administered to these 25 patients. The median time to recovery of an absolute neutrophil count of 500/[micro]l or greater was 13-14 days (range, 7-18 days) and time to recovery of a platelet count of 20,000/[micro]l or greater was 13-14 days (range, 7-16 days) after the initiation of each cycle of chemotherapy. The median number of platelet transfusions required after each cycle was 2-3 (range, 0-18 transfusions) and the number of erythrocyte transfusions was 4 (range, 0-10). The most common toxicity was diarrhea. Prophylactic intravenous antibiotics were administered to avoid fever with neutropenia. Two patients developed interstitial pneumonitis and one patient died. One heavily pretreated patient failed to engraft after the first cycle. Reversible veno-occlusive disease of the liver developed in one patient after the fourth cycle of therapy. Four patients progressed while on therapy. Eight patients were disease free and 13 patients had a partial response or had a positive bone scan as the only evidence of disease at the completion of therapy. Seven patients, two with lymphoma and five with breast cancer (28%), remain progression free with a median follow-up of 24.7 months (range, 17-28 months). Conclusions. Support with hematopoietic progenitor cells and growth factors allows the timely administration of repetitive cycles of high dose chemotherapy, resulting in a significant increase in dose intensity with acceptable toxicity. Cancer 1995; 76:860-8. Key words: hematopoietic progenitor cells, growth factors, dose intensity, dose response.

Published
1995

41. Psi4NumPy: An Interactive Quantum Chemistry Programming Environment for Reference Implementations and Rapid Development

Author

Smith, Daniel G. A., primary, Burns, Lori A., additional, Sirianni, Dominic A., additional, Nascimento, Daniel R., additional, Kumar, Ashutosh, additional, James, Andrew M., additional, Schriber, Jeffrey B., additional, Zhang, Tianyuan, additional, Zhang, Boyi, additional, Abbott, Adam S., additional, Berquist, Eric J., additional, Lechner, Marvin H., additional, Cunha, Leonardo A., additional, Heide, Alexander G., additional, Waldrop, Jonathan M., additional, Takeshita, Tyler Y., additional, Alenaizan, Asem, additional, Neuhauser, Daniel, additional, King, Rollin A., additional, Simmonett, Andrew C., additional, Turney, Justin M., additional, Schaefer, Henry F., additional, Evangelista, Francesco A., additional, DePrince, A. Eugene, additional, Crawford, T. Daniel, additional, Patkowski, Konrad, additional, and Sherrill, C. David, additional

Published
2018
Full Text
View/download PDF

42. Psi4NumPy: An Interactive Quantum Chemistry Programming Environment for Reference Implementations and Rapid Development

Author

Smith, Daniel, primary, Burns, Lori A, primary, Sirianni, Dominic A., primary, Nascimento, Daniel R., primary, Kumar, Ashutosh, primary, James, Andrew M., primary, Schriber, Jeffrey B., primary, Zhang, Tianyuan, primary, Zhang, Boyi, primary, Abbott, Adam S., primary, Berquist, Eric, primary, Lechner, Marvin H., primary, Cunha, Leonardo dos Anjos, primary, Heide, Alexander G., primary, King, Rollin A., primary, Simmonett, Andrew C., primary, Turney, Justin M., primary, Schaefer, Henry F., primary, Evangelista, Francesco A., primary, DePrince, A. Eugene, primary, Crawford, T. Daniel, primary, Patkowski, Konrad, primary, and Sherrill, C. David, primary

Published
2018
Full Text
View/download PDF

43. The Effect of Aging and Pre-Donation Comorbidities on the Related PBSC Donor Experience: A Report from the Related Donor Safety Study (RDSafe)

Author

Pulsipher, Michael, primary, Logan, Brent R., additional, Chitphakdithai, Pintip, additional, Kiefer, Deidre M., additional, Riches, Marcie L., additional, Rizzo, J. Douglas, additional, Anderlini, Paolo, additional, Leitman, Susan F., additional, Varni, James W., additional, Kobusingye, Hati, additional, Besser, RaeAnne M., additional, Miller, John P., additional, Drexler, Rebecca J., additional, Abdel-Mageed, Aly, additional, Ahmed, Ibrahim A., additional, Akard, Luke P., additional, Artz, Andrew S., additional, Ball, Edward D., additional, Bayer, Ruthee-Lu, additional, Bigelow, Carolyn, additional, Bolwell, Brian J., additional, Broun, E. Randolph, additional, Bunin, Nancy J., additional, Delgado, David C., additional, Duckworth, Katharine, additional, Dvorak, Christopher C., additional, Hahn, Theresa E., additional, Haight, Ann E., additional, Hari, Parameswaran N., additional, Hayes-Lattin, Brandon M., additional, Jacobsohn, David A., additional, Jakubowski, Ann A., additional, Kasow, Kimberly A., additional, Lazarus, Hillard M., additional, Liesveld, Jane L., additional, Linenberger, Michael, additional, Litzow, Mark R., additional, Longo, Walter, additional, Magalhaes-Silverman, Margarida, additional, McCarty, John M., additional, McGuirk, Joseph P., additional, Mori, Shahram, additional, Parameswaran, Vinod, additional, Prasad, Vinod K., additional, Rowley, Scott D., additional, Rybka, Witold B., additional, Sahdev, Indira, additional, Schriber, Jeffrey R., additional, Selby, George B., additional, Shaughnessy, Paul J., additional, Shenoy, Shalini, additional, Spitzer, Thomas, additional, Tse, William T., additional, Uberti, Joseph P., additional, Vusirikala, Madhuri, additional, Waller, Edmund K., additional, Weisdorf, Daniel J., additional, Yanik, Gregory A., additional, Navarro, Willis H., additional, Horowitz, Mary M., additional, Switzer, Galen E., additional, Shaw, Bronwen E., additional, and Confer, Dennis L., additional

Published
2018
Full Text
View/download PDF

45. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report

Author

Schriber, Jeffrey R., primary, Hari, Parameswaran N., additional, Ahn, Kwang Woo, additional, Fei, Mingwei, additional, Costa, Luciano J., additional, Kharfan‐Dabaja, Mohamad A., additional, Angel‐Diaz, Miguel, additional, Gale, Robert P., additional, Ganguly, Siddharatha, additional, Girnius, Saulius K., additional, Hashmi, Shahrukh, additional, Pawarode, Attaphol, additional, Vesole, David H., additional, Wiernik, Peter H., additional, Wirk, Baldeep M., additional, Marks, David I., additional, Nishihori, Taiga, additional, Olsson, Richard F., additional, Usmani, Saad Z., additional, Mark, Tomer M., additional, Nieto, Yago L., additional, and D'Souza, Anita, additional

Published
2017
Full Text
View/download PDF

46. No Differences in Stem Cell Transplantation Utilization Rates (STUR) by Ethnicity after Referral to a Transplant Center for Multiple Myeloma (MM): Implications for Improving Stur Rates in Minorities

Author

Schriber, Jeffrey, primary, Bean, Chris, additional, Simpson, Eileen, additional, Davis, Rebecca J., additional, Go, Aileen, additional, Fauble, Veena, additional, Abbas, Jonathan, additional, Chiffelle, Rochelle, additional, Sulski, Gail, additional, Thurman, Nicole, additional, Steenstra, Kate, additional, Gibson, Denise, additional, Szetela, Andrew, additional, Kendrick, Selma, additional, and Briggs, Adrienne, additional

Published
2017
Full Text
View/download PDF

50. Post Transplant Cytoxan in Patients over the Age of 60 Undergoing Allogeneic Transplant: Less Graft Versus Host Disease (GVHD) Related Deaths Than in Patients Treated with Standard Tacrolimus Methotrexate

Author

Schriber, Jeffrey, primary, Fauble, Veena, additional, Simpson, Eileen, additional, Steenstra, Kate, additional, Chiffelle, Rochelle, additional, Sulski, Gail, additional, Thurman, Nicole, additional, Go, Aileen, additional, Kendrick, Selma, additional, Abbas, Jonathan, additional, and Briggs, Adrienne, additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results